Generex And Dong-Sung Ink Deal For Oral Insulin Product In South Korea
This article was originally published in PharmAsia News
Executive Summary
Toronto-based Generex Biotechnology and Korean Dong-Sung Pharmaceutical have inked a deal to license and distribute Generex's oral insulin spray in South Korea, Generex announced Aug. 25